# cobas KRAS Mutation Test

Source: https://onco.cc/drugs/cobas-kras-mutation-test/  
OnCo record `cobas-kras-mutation-test` (Test). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Roche's PCR test that checks a bowel cancer for common KRAS mutations; a no-mutation result is what the FDA links to cetuximab or panitumumab.

## Summary

Roche Molecular Systems' cobas KRAS Mutation Test was approved on 7 May 2015 (PMA P140023). The FDA approval statement describes a real-time PCR test, run with the cobas 4800 System, for seven somatic mutations in codons 12 and 13 of KRAS in colorectal cancer tissue, intended as an aid in identifying patients for whom cetuximab or panitumumab may be indicated based on a no mutation detected result. The FDA companion diagnostic list carries it for both drugs. It reads KRAS codons 12 and 13 only; some tests the list carries for panitumumab, such as the CRCDx RAS kit, also read NRAS and further KRAS exons.

## Fields

- Kind: Test
- Status: approved
- Last checked: 2026-11-19
- Also known as: Roche cobas KRAS Mutation Test
- Tags: test
- Brand: cobas KRAS Mutation Test
- Modality: Real-time PCR companion diagnostic test (KRAS codons 12 and 13, colorectal tumour tissue)
- Mechanism: Real-time PCR on the cobas 4800 System that detects seven somatic mutations in codons 12 and 13 of the KRAS gene in DNA from formalin-fixed, paraffin-embedded colorectal tumour tissue.
- Approvals: US 2015: KRAS codon 12 and 13 no mutation detected, as an aid in selecting cetuximab or panitumumab in colorectal cancer

## Sources

- openFDA PMA record P140023 (original approval): https://api.fda.gov/device/pma.json?search=pma_number:P140023+AND+supplement_number:%22%22
- FDA PMA P140023: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P140023
- FDA: List of FDA-Authorized Companion Diagnostic Devices: https://www.fda.gov/medical-devices/in-vitro-diagnostics/list-fda-authorized-companion-diagnostic-devices-in-vitro-and-imaging-tools

## Connected records

- drugs: [Cetuximab](https://onco.cc/drugs/cetuximab/), [CRCDx RAS Mutation Detection Assay Kit](https://onco.cc/drugs/crcdx-ras/), [ONCO/Reveal Dx Lung and Colon Cancer Assay](https://onco.cc/drugs/onco-reveal-dx-lung-colon/), [Panitumumab](https://onco.cc/drugs/panitumumab/)
- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/)
- technologies: [Companion diagnostics](https://onco.cc/technologies/companion-diagnostic/)
- targets: [KRAS](https://onco.cc/targets/kras/)
- companies: [Roche / Genentech](https://onco.cc/companies/roche-genentech/)
- terms: [Companion diagnostic](https://onco.cc/terms/companion-diagnostic-term/), [Pathologic complete response (pCR)](https://onco.cc/terms/pcr/)

---
JSON: https://onco.cc/api/v1/entities/cobas-kras-mutation-test.json